The journal retracts the 24 February 2021 article cited above.
Following publication, it was brought to our attention that substantial sections of this article have been previously published. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies.
This retraction was approved by the Chief Editors of Frontiers in Medicine and the Chief Executive Editor of Frontiers. Yong Guo does not agree to the retraction. All other authors agree to this retraction.
Summary
Keywords
glucocorticoid, COVID-19, SARS-CoV-2, Pneumonia, Inflammation
Citation
Frontiers Editorial Office (2022) Retraction: Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2. Front. Med. 9:947016. doi: 10.3389/fmed.2022.947016
Received
18 May 2022
Accepted
18 May 2022
Published
31 May 2022
Approved by
Michel Goldman, Institute for Interdisciplinary Innovation in Healthcare (I3h), Belgium
Volume
9 - 2022
Updates
Copyright
© 2022 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office editorial.office@frontiersin.org
This article was submitted to Intensive Care Medicine and Anesthesiology, a section of the journal Frontiers in Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.